RazorMetrics Achieves No. 20 on Deloitte's Technology Fast 500 Once Again

RazorMetrics, an Austin-based innovator in pharmacy cost containment technology, has been recognized for its outstanding growth in the tech industry, securing the No. 20 spot on the 2026 Deloitte Technology Fast 500™ list. This ranking highlights the fastest-growing technology companies in North America based on their revenue growth over a three-year period. RazorMetrics achieved an astonishing growth rate of 4488% from 2022 to 2025, illustrating the increasing demand for its AI-driven prescription drug cost containment solutions.

Continuing its success from the previous year, when it ranked No. 12 overall, RazorMetrics has again captured the attention of the industry. The company also topped the list in Texas and placed third within the Health Tech and Medical Devices sector nationally, further solidifying its standing as a leader in the market.

The growth of RazorMetrics can be attributed to its commitment to providing healthcare organizations with tools to tackle escalating prescription drug costs. By integrating into healthcare providers' existing workflows, their platform helps identify more affordable and clinically appropriate alternative medications, ultimately aiming to reduce unnecessary expenses while ensuring positive patient outcomes.

Tom Dorsett, CEO and co-founder of RazorMetrics, expressed pride in the company's accomplishments, stating, "Our growth reflects the results we're delivering to clients, and we're honored to be recognized by Deloitte for a second year. Being named No. 1 in Texas is especially meaningful for us as an Austin-based company."

In 2026, RazorMetrics not only maintained its innovative cost containment approach but also expanded its national reach, growing its provider network to include nearly 1.7 million unique prescribers across the United States. This network expansion allows the company to better serve its clients by providing timely, patient-specific alternatives that physicians can incorporate into their care practices.

RazorMetrics also conducted a survey involving over 100 U.S. physicians to understand the impact of drug costs on medical treatments and the challenges healthcare professionals face in navigating prescription affordability. The findings highlighted how essential it is for healthcare providers to have access to tools that allow them to present lower-cost alternatives during their prescribing process without compromising care quality.

Siva Mohan, MD, co-founder and president of RazorMetrics, emphasized the company’s dedication to understanding physicians’ challenges, asserting that their success is rooted in listening closely and developing technology tailored to enhance the prescribing process. "RazorMetrics was built on the belief that organizations should not have to choose between managing prescription drug costs and helping members access the medications they need."

The 2026 Technology Fast 500 featured a wide range of impressive companies, with revenue growth rates varying from 97% to an extraordinary 66,330%. The average growth rate among winners reached 1,134%, showcasing the rapid evolution present within the tech sector.

For further insights into RazorMetrics’ groundbreaking work in pharmacy cost containment, visit www.razormetrics.com. This recognition is not just a badge of honor for RazorMetrics; it represents a vital step towards transforming the healthcare landscape by making medications more accessible, affordable, and tailored to the needs of patients and healthcare providers alike.

About the 2026 Deloitte Technology Fast 500


Established 32 years ago, the Deloitte Technology Fast 500 ranks North America’s fastest-growing technology companies, both public and private. The awards celebrate companies based on their fiscal year revenue growth percentage over three years. Eligible companies must possess proprietary technology that contributes significantly to their operational revenues and must have been in business for a minimum of four years.

In essence, RazorMetrics not only exemplifies technological innovation but also embodies a commitment to improving healthcare affordability and accessibility through intelligent solutions that benefit both providers and patients across the board.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.